Mass Spectrometry Imaging Market Growth Accelerates: Strategic Forecast Predicts $4.07 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Mass Spectrometry Imaging Industry Market Size Be by 2025?
In recent years, the market size for mass spectrometry imaging has seen a robust growth. Projections show it rising from $2.65 billion in 2024 to $2.88 billion in 2025, representing a compound annual growth rate (CAGR) of 8.8%. This growth over the historical period is primarily fueled by factors such as the growing adoption in pharmaceutical research, the surging demand for tailor-made medicine, an increase in applications for cancer diagnostics, a rising number of activities for drug discovery and development, and enhanced funding in the field of biomedical research.

What's the Long-Term Growth Forecast for the Mass Spectrometry Imaging Market Size Through 2029?
The market size for mass spectrometry imaging is predicted to significantly increase in the forthcoming years, to reach $4.07 billion in 2029, growing at a Compound Annual Growth Rate (CAGR) of 9.0%. This anticipated growth within the projection period is attributable to an intensified focus on spatial omics studies, higher usage in the identification of biomarkers, increased integration with tools powered by artificial intelligence, broader applications in the realm of clinical diagnostics, and a surge in the demand for high-resolution imaging techniques. Notable trends expected within the forecast period include enhancements in high-resolution mass spectrometry technologies, progressive integration of imaging software, innovation in the techniques used for sample preparation, advancements in hybrid imaging modalities, and heightened automation in the analysis of data workflows.

View the full report here:
https://www.thebusinessresearchcompany.com/report/mass-spectrometry-imaging-global-market-report

What Are the Key Growth Drivers Fueling the Mass Spectrometry Imaging Market Expansion?
The surge in the need for personalized medicine is anticipated to propel the expansion of the mass spectrometry imaging market. This type of medical care is tailored to each patient, taking into account their genetic composition, environment, and way of life to enhance effectiveness. The growth of personalized medicine is fueled by advancements in genomics, which allows for the provision of targeted treatments based on genetic profiles, leading to increased efficacy and fewer side effects. Mass spectrometry imaging aids personalized medicine by generating comprehensive molecular maps of tissues, assisting in the detection of disease biomarkers, and facilitating the creation of targeted therapies designed for individual patient profiles. For example, in February 2024, as per the Personalized Medicine Coalition, a non-profit organization based in the US, there were 16 new personalized treatment options approved by the FDA for patients with rare diseases in 2023, a marked rise from the six authorized in 2022. Therefore, the burgeoning need for personalized medicine is contributing to the growth of the mass spectrometry imaging market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24288&type=smp

What Are the Key Trends Driving Mass Spectrometry Imaging Market Growth?
Leading companies in the mass spectrometry imaging (MSI) market are putting their energy into creating innovative technology, like desorption electrospray ionization, in the hopes of providing more accurate and comprehensive molecular analyses for a variety of uses. Desorption electrospray ionization (DESI) is an ionization process that utilizes a charged solvent spray to extract ions from surfaces under ambient conditions. It allows the direct analysis of solid samples like tissues without requiring any preparation or extraction of the sample. For example, in June 2023, the US-based analytical laboratory instrument manufacturer, Waters Corporation, introduced a new targeted imaging mass spectrometer to the market. This instrument enhances tissue analysis by increasing its sensitivity and speed. It delivers more accurate small-molecule drug analysis and offers a higher resolution when used for targeted imaging. The instrument allows quicker detection which accelerates biological studies. The device improves both accuracy and efficiency which substantially aids research processes. This innovation is a huge boon for advanced drug development and biological research as it gives researchers access to detailed, high-quality data.

How Is the Mass Spectrometry Imaging Market Segmented?
The mass spectrometry imaging market covered in this report is segmented -

1) By Product Type: Instruments, Consumables, Services
2) By Technology: Matrix-Assisted Laser Desorption Or Ionization (MALDI), Secondary Ion Mass Spectrometry (SIMS), Desorption Electrospray Ionization (DESI), Magnetic Sector Mass Spectrometry, Time-of-Flight Mass Spectrometry (TOFMS), Other Technologies
3) By Application: Proteomics, Metabolomics, Glycomics, Other Applications
4) By End-User: Pharmaceutical and Biotechnology Companies, Government and Academic Institutions, Other End-Users

Subsegments:
1) By Instruments: High-Resolution Mass Spectrometers, Imaging Mass Spectrometers, Matrix-Assisted Laser Desorption Or Ionization Time-of-Flight System, Liquid Chromatography-Mass Spectrometry System, Quadrupole Time-of-Flight Mass Spectrometers, Tandem Mass Spectrometers
2) By Consumables: Reagents And Chemicals, Sample Preparation Kits, Mass Spectrometry Plates And Slides, Calibration Standards, Solvents And Buffers
3) By Services: Installation And Maintenance Services, Data Analysis And Software Services, Training And Support Services, Consultation And Customization Services

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24288&type=smp

Which Companies Are Leading the Charge in Mass Spectrometry Imaging Market Innovation?
Major companies operating in the mass spectrometry imaging market are Thermo Fisher Scientific Inc., Danaher Corporation, Hitachi High-Tech Corporation, Shimadzu Corporation, Waters Corporation, Bruker Corporation, Horiba Scientific, JEOL Ltd., SCIEX, Analytik Jena AG, Standard BioTools, TOFWERK AG, Advion Inc., MassTech Inc., CovalX AG, ImaBiotech SAS, MassAnalytica LLC, Ionwerks Inc., Biognosys AG, Spectroswiss Sàrl

Which Regions Are Leading the Global Mass Spectrometry Imaging Market in Revenue?
North America was the largest region in the mass spectrometry imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mass spectrometry imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24288

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.